Unknown

Dataset Information

SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer.


ABSTRACT: Prostate cancer is the most commonly diagnosed malignancy for men in the United States. Metastatic prostate cancer, the lethal form of the disease, has a life expectancy of approximately five years. Identification of factors associated with this transition to metastatic disease is crucial for future therapies. One such factor is the SSX gene family, a family of cancer/testis antigens (CTA) transcription factors which have been shown to be aberrantly expressed in other cancers and associated with the epithelial to mesenchymal transition (EMT). We have previously shown that SSX expression in prostate cancers was restricted to metastatic tissue and not primary tumors. In this study, we have identified SSX2 as the predominant SSX family member expressed in prostate cancer, and found its expres

SUBMITTER: Bloom JE 

PROVIDER: S-EPMC5239454 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature